title: [Current recommendations for the treatment of preeclampsia].
abstract: Low-dose aspirin, but not vitamin C and vitamin E, has small to moderate benefits when used for the prevention of preeclampsia. There is however little to suggest that the course of manifest preeclampsia can be substantially affected by drug treatment. Antihypertensive therapy increases the risk of fetal growth restriction and is only indicated in severe hypertension to reduce the risk of maternal cerebral hemorrhage. Magnesium sulfate is the drug of choice for the prevention and treatment of eclampsia. Volume expansion as well as the use of steroids in preeclamptic patients without HELLP syndrome have failed to show any improvement. Delivery as the only definitive treatment is always beneficial for the mother whereas expectant management is in favor of a premature fetus. Decision-making largely depends on gestational age and severity of the disease.
authors.affiliation: Klinik und Poliklinik fur Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster, Münster, Deutschland.
authors.forename: W
authors.initials: W
authors.lastname: Klockenbusch
authors.forename: F
authors.initials: F
authors.lastname: Schrepfer
mesh_terms: D005260:Female; D005858:Germany; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards*; D011225:Pre-Eclampsia / Q000628:therapy*; D011247:Pregnancy